Pfizer has selected PAREXEL International and ICON plc as preferred providers for clinical trial services. PAREXEL will work with Pfizer under a five-year agreement to provide clinical development services and expertise on a global basis combined with its eClinical technology platform. Under the partnership agreement with ICON, Pfizer will leverage ICON’s expertise in the areas of program initiation and management, site and country feasibility, data management and reporting set-up, program s...